Skip to content
Broadly Epi

Broadly Epi

Epidemiology, Broadly Speaking

  • Home
  • Rent-A-Scientist
  • Software
    • Broadly Epi MMWR Archive Database
    • HSE Specialty Care Finder
  • Data Rebellion
    • Social Vulnerability Index Archive and Data Mart
  • Care Resources
    • LGBTQIA+ Health Resources
    • Health Care Affordability Resources
    • List of Resources for People Who Use Drugs
  • Blog
    • Epi Explained: Simplified Epidemiology Concepts
    • MMWR Booster: Simplified Research
    • Python Tutorials
    • R Tutorials
    • Emerging Study
    • Community Experts
  • Contact Us

Tag: Infectious Disease

MMWR Booster for: Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022, December 30, 2022 / 71(5152);1605–1609

Posted on January 1, 2024 by Cody Micah Carmichael MPH, CPH

In this entry of MMWR Booster, a summary is provided about findings regarding Clinical and Epidemiological Data in regards to Mpox in Gender Diverse Persons.

MMWR Booster 2022, Infectious Disease, LGBTQIA+, MMWR Boosters, MPox Leave a comment

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022, Weekly / March 17, 2023 / 71(53);1637–1646

Posted on January 1, 2024 by Cody Micah Carmichael MPH, CPH

In this entry of MMWR Booster, a summary is provided about findings regarding COVID mRNA Vaccine effectiveness in preventing severe hopsitalizations and outcomes.

MMWR Booster COVID, Infectious Disease, MMWR Boosters, mRNA Vaccine Leave a comment
  • ← Previous
  • 1
  • …
  • 10
  • 11
  • 12

Search

Categories

Recent Posts

  • Community Experts Issue 3: Rowan Odom’s Story – Living with an Undiagnosed Chronic Illness February 1, 2025
  • MMWR Booster for: Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021 / February 25, 2022 / 71(8);290–292 January 11, 2025
  • MMWR Booster for: Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020 / September 3, 2021 / 70(35);1201–1205 January 10, 2025
  • MMWR Booster for: Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021 / February 25, 2022 / 71(8);299–305 January 10, 2025
  • MMWR Booster for: Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021 / September 3, 2021 / 70(35);1195–1200 January 9, 2025
  • MMWR Booster for: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 / March 4, 2022 / 71(9);352–358 January 9, 2025
  • MMWR Booster for: Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 / February 25, 2022 / 71(8);285–289 January 8, 2025
  • MMWR Booster for: Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States, 2017–2019 / September 3, 2021 / 70(35);1191–1194 January 8, 2025
  • MMWR Booster for: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 / March 4, 2022 / 71(9);347–351 January 7, 2025
  • MMWR Booster for: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 / September 3, 2021 / 70(35);1183–1190 January 7, 2025
  • Github
  • BlueSky
  • Threads
  • LinkedIn

Notifications